Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication June 3, 2017
- Published online January 1, 2018.
Article Versions
- Latest version (August 15, 2017 - 04:03).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 Free online via JRheum Full Release option
Author Information
- Edward C. Keystone⇑,
- Mark C. Genovese,
- Douglas E. Schlichting,
- Inmaculada de la Torre,
- Scott D. Beattie,
- Terence P. Rooney and
- Peter C. Taylor
- From the Rebecca MacDonald Centre for Arthritis and Autoimmune Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana, USA; Kennedy Institute of Rheumatology and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
- E.C. Keystone, MD, The Rebecca MacDonald Centre for Arthritis and Autoimmune Diseases, Mount Sinai Hospital; M.C. Genovese, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine; D.E. Schlichting, RN, PhD, Eli Lilly and Company; I. de la Torre, MD, PhD, Eli Lilly and Company; S.D. Beattie, PhD, Eli Lilly and Company; T.P. Rooney, MD, Eli Lilly and Company; P.C. Taylor, MA, PhD, FRCP, FRCPE, Kennedy Institute of Rheumatology and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.
- Address correspondence to Dr. E.C. Keystone, The Rebecca MacDonald Centre for Arthritis and Autoimmune Diseases, Mount Sinai Hospital, 60 Murray St., Room 2-006, Box 4, Toronto, Ontario M5T 3L9, Canada. E-mail: Ed.Keystone{at}sinaihealthsystem.ca
